OCX logo

OncoCyte (OCX)

Profile

Full Name

OncoCyte Corporation

Ticker Symbol

OCX

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

December 30, 2015

Indexes

Not included

Website

http://www.oncocyte.com

Employees

46

Key Details

Price

$2.78(-4.14%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.88M(+25.15% YoY)

Annual EPS

-$4.66(-24.27% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.78
OCX price is $2.78

30-Day Relative Volume

0.42
OCX 30-day relative volume is 0.42

Price Performance

Price Most recent change

-4.14%
OCX price was down -4.14% on Apr 11, 2025

Price YTD change

+16.81%
OCX price is up +16.81% since January 1st

Price 1-year change

+2.58%
OCX price is up +2.58% year-on-year

Price 3-year change

-88.97%
OCX price is down -88.97% over the past 3 years

Price Range

Price All-time high

$204.80
OCX price is currently -98.64% below its historical high of $204.80

Price 3-year low

$1.92
OCX price is currently +44.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$79.51M
OCX market capitalization is $79.51 million

Market cap 3-year change

-31.6%
OCX market capitalization is down -31.6% over the past 3 years

Market cap All-time high

$569.45M
OCX market capitalization is currently -86.04% below its historical high of $569.45 million

Market cap sector rank

45.77%
OCX market capitalization is higher than 45.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+245.69%
OCX shares outstanding is up +245.69% year-on-year

Shares Outstanding 3-Year Change

+520.07%
OCX shares outstanding is up +520.07% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.28
OCX beta is 0.28

200-day SMA

$2.85
OCX price is currently -2.31% below its 200-day simple moving average

50-day SMA

$2.95
OCX price is currently -5.81% below its 50-day simple moving average

RSI

40.96
OCX 14-day relative strength index is 40.96

Volume

0.42
OCX 30-day relative volume is 0.42

ATR

$0.29
OCX average true range is $0.29

10-day Historical Volatility

59.52%
OCX 10-day historical volatility is 59.52%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.88M
OCX annual revenue is $1.88 million

Revenue Analysts estimate

$1.02M
OCX annual revenue is currently +83.68% higher than the consensus analysts' forecast

Revenue 1-year change

+25.15%
OCX annual revenue is up +25.15% year-on-year

Revenue Sector rank

14.89%
OCX annual revenue is higher than 14.89% of companies in Healthcare sector

EPS

EPS

-$4.66
OCX annual earnings per share is -$4.66

EPS Analysts estimate

-$0.97
OCX annual earnings per share is currently +380.41% higher than the consensus analysts' forecast

EPS 1-year change

-24.27%
OCX annual earnings per share is down -24.27% year-on-year

EPS Sector rank

20.48%
OCX annual earnings per share is higher than 20.48% of companies in Healthcare sector

Profit

Gross profit

$740.00K
OCX annual gross profit is $740.00 thousand

Gross margin

39.34%
OCX annual gross profit margin is 39.34%

Operating profit

-$23.25M
OCX annual operating income is -$23.25 million

Operating margin

-1235.89%
OCX annual operating profit margin is -1235.89%

Net income

-$60.66M
OCX annual net profit is -$60.66 million

Net margin

-3225.04%
OCX annual net profit margin is -3225.04%

Expenses

Total expenses

$25.13M
OCX annual total expenses is $25.13 million

Operating expenses

$23.99M
OCX annual total operating expenses is $23.99 million

Cost of goods sold

$1.14M
OCX annual cost of goods sold is $1.14 million

Selling, general & administrative expenses

$13.79M
OCX annual SGA is $13.79 million

Depreciation and amortization

$1.56M
OCX annual depreciation & amortization is $1.56 million

Interest expense

$84.00K
OCX annual interest expense is $84.00 thousand

Income tax

-
OCX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$60.58M
OCX annual earnings before interest & taxes is -$60.58 million

EBITDA

-$59.02M
OCX annual EBITDA is -$59.02 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$35.08M
OCX annual total assets is $35.08 million

Non current assets

$23.32M
OCX annual long term assets is $23.32 million

Current assets

$11.76M
OCX annual total current assets is $11.76 million

Cash and cash equivalents

$8.64M
OCX annual cash & cash equivalents is $8.64 million

Accounts receivable

$1.61M
OCX annual accounts receivable is $1.61 million

Inventory

$410.00K
OCX annual inventory is $410.00 thousand

Liabilities

Total liabilities

$47.35M
OCX annual total liabilities is $47.35 million

Long term liabilities

$40.08M
OCX annual total long term liabilities is $40.08 million

Current liabilities

$7.28M
OCX annual total current liabilities is $7.28 million

Accounts payable

$2.28M
OCX annual accounts payable is $2.28 million

Debt

Total debt

$3.66M
OCX annual total debt is $3.66 million

Total debt 1-year change

+27.71%
OCX annual total debt is up +27.71% year-on-year

Long term debt

$2.37M
OCX annual long term debt is $2.37 million

Short term debt

$1.29M
OCX annual short term debt is $1.29 million

Equity & Capital

Shareholders equity

-$12.27M
OCX annual stockholders equity is -$12.27 million

Book value

-$12.27M
OCX annual book value is -$12.27 million

Retained earnings

-$350.54M
OCX annual retained earnings is -$350.54 million

Working capital

$4.48M
OCX annual working capital is $4.48 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$20.71M
OCX annual cash flow from operations is -$20.71 million

Cash from operations 1-year change

+11.2%
OCX annual cash flow from operations is up +11.2% year-on-year

Cash from investing

-$512.00K
OCX annual cash flow from investing activities is -$512.00 thousand

Cash from investing 1-year change

+45.06%
OCX annual cash flow from investing activities is up +45.06% year-on-year

Cash from financing

$20.43M
OCX annual cash flow from financing activities is $20.43 million

Cash from financing 1-year change

+67.64%
OCX annual cash flow from financing activities is up +67.64% year-on-year

CAPEX

CAPEX

$516.00K
OCX annual capital expenditures is $516.00 thousand

CAPEX 1-year change

+83.63%
OCX annual capital expenditures is up +83.63% year-on-year

Free Cash Flow

Free cash flow

-$21.23M
OCX annual free cash flow is -$21.23 million

Free cash flow 1-year change

+10.07%
OCX annual free cash flow is up +10.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

39.34%
OCX annual gross profit margin is 39.34%

Operating margin

-1235.89%
OCX annual operating profit margin is -1235.89%

Net margin

-3225.04%
OCX annual net profit margin is -3225.04%

ROA & ROE

ROA

-110.32%
OCX annual return on assets is -110.32%

ROE

-1480.67%
OCX annual return on equity is -1480.67%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OCX price to earnings ratio value is unknown

PE ratio Sector rank

-
OCX price to earnings ratio is unknown

PB Ratio

PB ratio

-6.48
OCX price to book ratio is -6.48

PB ratio Sector rank

3.04%
OCX price to book ratio is higher than 3.04% of companies in Healthcare sector

PS Ratio

PS ratio

42.27
OCX price to sales ratio is 42.27

PS ratio Sector rank

91.67%
OCX price to sales ratio is higher than 91.67% of companies in Healthcare sector

Enterprise value

Enterprise value

$74.53M
OCX enterprise value is $74.53 million

Enterprise value Sector rank

46.66%
OCX enterprise value is higher than 46.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.26
OCX EV/EBITDA is -1.26

EV/EBITDA Sector rank

38.84%
OCX EV/EBITDA is higher than 38.84% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.62
OCX annual current ratio is 1.62

Quick ratio

1.56
OCX annual quick ratio is 1.56

Leverage

Debt to equity

0.00
OCX annual debt to equity ratio is 0.00

Interest coverage ratio

-721.18
OCX annual interest coverage ratio is -721.18

Risk & Stability

Piotroski F-Score

4
OCX piotroski f-score is 4

Altman Z-Score

-18.47
OCX altman z-score is -18.47

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Mar 28, 25 Lake Street
Buy
Mar 26, 25 Stephens & Co.
Equal-Weight
Mar 25, 25 Stephens & Co.
Equal-Weight
Mar 25, 25 Needham
Buy
Aug 9, 24 Needham
Buy
May 16, 24 Needham
Buy
Apr 24, 24 Needham
Buy
Apr 17, 24 Stephens & Co.
Equal-Weight
Apr 15, 24 Benchmark
Speculative Buy

Institutional Ownership

Similar stocks

Elicio Therapeutics (ELTX)
CRDL logo
Cardiol Therapeutics (CRDL)
VERU logo
Veru (VERU)
Telomir Pharmaceuticals (TELO)
TNYA logo
Tenaya Therapeutics (TNYA)
BDTX logo
Black Diamond Therapeutics (BDTX)
CRBU logo
Caribou Biosciences (CRBU)
MDXH logo
MDxHealth SA (MDXH)
MGNX logo
MacroGenics (MGNX)
  • What is the ticker symbol for OncoCyte?
  • Does OncoCyte pay dividends?
  • What sector is OncoCyte in?
  • What industry is OncoCyte in?
  • What country is OncoCyte based in?
  • When did OncoCyte go public?
  • Is OncoCyte in the S&P 500?
  • Is OncoCyte in the NASDAQ 100?
  • Is OncoCyte in the Dow Jones?
  • When was OncoCyte's last earnings report?
  • When does OncoCyte report earnings?
  • Should I buy OncoCyte stock now?

What is the ticker symbol for OncoCyte?

The ticker symbol for OncoCyte is NASDAQ:OCX

Does OncoCyte pay dividends?

No, OncoCyte does not pay dividends

What sector is OncoCyte in?

OncoCyte is in the Healthcare sector

What industry is OncoCyte in?

OncoCyte is in the Diagnostics & Research industry

What country is OncoCyte based in?

OncoCyte is headquartered in United States

When did OncoCyte go public?

OncoCyte's initial public offering (IPO) was on December 30, 2015

Is OncoCyte in the S&P 500?

No, OncoCyte is not included in the S&P 500 index

Is OncoCyte in the NASDAQ 100?

No, OncoCyte is not included in the NASDAQ 100 index

Is OncoCyte in the Dow Jones?

No, OncoCyte is not included in the Dow Jones index

When was OncoCyte's last earnings report?

OncoCyte's most recent earnings report was on Mar 24, 2025

When does OncoCyte report earnings?

The next expected earnings date for OncoCyte is May 15, 2025

Should I buy OncoCyte stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page